Tissues were prepared and in situ hybridizations were performed as described in Norman et al.
5 The riboprobes for
K15 (277 bp), WDNM1-like protein (223 bp) and marapsin (360 bp) were made by in vitro transcription of the cDNA fragments cloned in the pSPT 19 vector. An
EcoRI site in the forward primers and
HindIII site in the reverse primers were introduced to facilitate cloning of the PCR products in the pSPT 19 vector. The inserted fragments were generated by PCR amplification using the following specific primers:
K15 (F [forward]: 5′-GCCAAACCT
GAATTCCACATCAGCGT-3′; R [reverse] 5′-CACT
AAG-CTTGGAACAGCCACCTACA-3′); WDNM1-like protein (F: 5′-GGTCACC
GAATTCTTTTAGGCACCTGT-3′; R: 5′-CCACG
AAGCTTAAACACC-GCCTTGTC-3′); and marapsin (F: 5′-CTTGAG
GAATTCTGGAGGCCCATTGGTA-3′; R: 5′-AGGAGCTG
AAGCTTAAGATAGGGGGACA-3′). Trans-formants (One Shot TOP 10 Electrocomp
Escherichia coli; Invitrogen) were identified by PCR and confirmed by nucleotide sequencing. The purified plasmids were linearized with
EcoRI (for antisense probe) and with
HindIII (for sense probe), and treated with proteinase K and served as templates for antisense and sense digoxigenin-labeled riboprobe synthesis using an RNA labeling kit (DIG Ki; SP6/T7; Roche Molecular Biochemicals, Indianapolis, IN).
For RT-PCR, total RNAs were extracted from central corneal, limbal and conjunctival epithelium (SNAP Total RNA Isolation Kit; Invitrogen). Conjunctival epithelium was scraped at the region far from the limbus to avoid contamination. RT-PCR was performed using 12 ng total RNA, gene-specific primers, and Taq polymerase (SuperScript One-Step RT-PCR with Platinum Taq; Invitrogen).
The primers used for these reactions were as follows: K15 (F: 5′-AGCAATTTCCACATCAGCGT-3′; R: 5′-TGAAGGAACAGCCACCTACA-3′); WDNM1-like protein (F: 5′-TGCAGCTTTTAGGCACCTGT-3′; R: 5′-AAAAGAAACACCGCCTTGTC-3′); chemokine (C-C motif) ligand 6: (F: 5′-TCAGAGAGTTCAGACGTGCA-3′; R: 5′-TGGGGGTCACTTACTGCTCT-3′); membrane-spanning 4-domain, subfamily A, member 8B (F: 5′-AACCACCCAACCCAATACCA-3′; R: 5′-TATCCCCAAAGCTCCTGTAG-3′); mesothelin (F: 5′-AGATACGTTAGCCCTGAGGA-3′; R: 5′-TTTGGCAATGACCCCTGGTA-3′); CD74 antigen (invariant polypeptide of major histocompatibility class II antigen associated) (F: 5′-AGCCCTTCTTACACTCCCTA-3′; R: 5′-TCACGTGAACCATGGTCCTA-3′); marapsin (F: 5′-ACTCTGGAGGCCCATTGGTA-3′; R: 5′-GGATGTAAGATAG-GGGGACA-3′); secretory (zymogen) granule membrane glycoprotein GP2 (F: 5′-GTCCTCTTGAATAGGGGTGA-3′; R: 5′-TTCTGCCCACTATCAGGACA-3′); EST (expressed sequence tag; Rn.30331) (F: 5′-AA-GTGCCTTGTACTGCCTGA-3′; R: 5′-GCAGACCATAAGACCTCCGT-3′); EST (Rn.9974) (F: 5′-TGTCTGACTCTGGCAGCACT-3′; R: 5′-CAGTA-TCTTGCTCTCACAGCT-3′); peptidyl arginine deiminase, type 1 (F: 5′-GCTGTTGGTCCAGATGTGAA-3′ R: 5′-AGAAGACTTGCTCCCATGCT-3′); and EST (Rn.96234) (F: 5′-AGTCCAAACTGAGCAGCACA-3′; R: 5′-CGGTATCTTAGCCCTCTCTA-3′).
The amplified PCR products were subjected to electrophoresis on a 1.5% agarose gel containing ethidium bromide.